-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster II

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Marta Anna Sobas, MD, PhD1*, Angela Villaverde Ramiro2*, Alberto Hernández Sánchez, MD3*, Javier Martinez Elicegui2*, Teresa González, PhD4*, Raúl Azibeiro Melchor5*, María Abáigar6*, Laura Tur7*, Daniele Dall'Olio, PhD8*, Eric Sträng, PhD9*, Jesse M. Tettero10*, Castellani Gastone, PhD11*, Axel Benner12*, Konstanze Döhner, MD13, Christian Thiede, MD14, Amin T. Turki, MD15, Klaus H. Metzeler, MD16, Torsten Haferlach, MD17, Frederick Damm, MD9*, Rosa Ayala18*, Joaquín Martínez-López, MD, PhD19*, Ken I Mills, BSc, PhD, FRCPath20, Jorge Sierra, MD, PhD21, Sören Lehmann22, Matteo G. Della Porta, MD23*, Jiri Mayer24, Dirk Reinhardt, MD25, Rubén Villoria Medina7*, Renate Schulze-Rath26*, Martje Barbus, PhD27*, Jesús María Hernández-Rivas, MD, PhD28, Brian Huntly, MB ChB, FRCPath, FMedSci, PhD29, Gert Ossenkoppele, MD30, Hartmut Dohner, MD31 and Lars Bullinger, MD32

1Department of Hematology, Blood Neoplasm and Bone Marrow Transplantation, Hosp. Clinico Univ. de Santiago de Compostela, Santiago de Compostela, Spain
2Molecular Genetics in Oncohematology, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
3Hematology Department, University Hospital of Salamanca, Salamanca, Spain
4Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
5Hospital Universitario de Burgos, Burgos, Spain
6Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
7GMV Innovating Solutions, Valencia, Spain
8University of Bologna, Bologna, Italy
9Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany
10Department of Hematology, Amsterdam University Medical Center location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
11Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, Bologna, Italy
12Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
13Division of Hematology and Oncology, University Hospital Ulm, Ulm, Germany
14Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
15Department of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, Germany
16Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
17MLL Munich Leukemia Laboratory, Munich, Germany
18Hospital Universitario 12 de Octubre, Madrid, Spain
19Hematology Department, Hospital Universitario 12 de Octubre, CNIO, Complutense University, Madrid, Spain
20Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom
21Hospital Santa Creu Sant Pau, Barcelona, Spain
22Uppsala University Hospital, Uppsala, Sweden
23Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy, Italy
24Hematology and Oncology, University Hospital Brno, Czech Republic, Brno, Czech Republic
25Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany
26Bayer AG, Pharmaceuticals Division, Berlin, Berlin, Germany
27AbbVie Deutschland GmbH & Co KG, Wiesbaden, DEU
28Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
29Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, ENG, United Kingdom
30Vrye Universiteit Academic Medical Center, Amsterdam, NLD
31Internal Medicine III, University of Ulm, Ulm, Germany
32Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany

Mohammad Ammad Ud Din, MBBS1,2 and Kendra Sweet, MD3

1Hematology/ Oncology, University of South Florida, Tampa, FL
2H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Talha Badar, MD1, Ehab L. Atallah, MD2, Antoine N. Saliba, MD3, Rory M. Shallis, MD4, Maximilian F. Stahl, MD5, Jan Philipp Bewersdorf, MD6, Guillerhme Sacchi De Camargo Correia, MD7*, Anand Ashwin Patel, MD8, Yasmin Abaza, MD9, Guru Subramanian Guru Murthy, MD10*, Adam S Duvall, MD11, Madelyn Burkart, MD12, Neil Palmisiano, MD, MS13, Danielle Bradshaw, MD14*, Vamsi K. Kota, MD14, Shira Dinner, MD9, Aaron D Goldberg, MD, PhD15 and Mark R. Litzow, MD3

1Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
2Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
3Division of Hematology, Mayo Clinic, Rochester, MN
4Yale University School of Medicine, New Haven, CT
5Department of Medical Oncology, Dana-Farber Institute, Boston, MA
6Department of Internal Medicine, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT
7Mayo Clinic, Florida
8Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL
9Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
10Medical College of Wisconsin, Milwaukee, WI
11Department of Medicine, University of Chicago, Chicago, IL
12Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
13Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA
14Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
15Memorial Sloan Kettering Cancer Center, New York, NY

Ivy Abraham, MD1, Garth Rauscher, PhD, MPH2*, Anand Ashwin Patel, MD3, Sarah Monick, MD4*, Madelyn Burkhart, MD5*, Eshana Shah, MD6, Ami Dave, MD7*, Matthew Kroll, MD8*, Stephanie B. Tsai, MD, MS9, Stephanie Berg, DO10, Amani Erra, MD11, Vedavyas Gannamani11*, Maryam Zia12, Melissa L. Larson, MD13, Wendy Stock, MD14, Jessica K. Altman, MD5 and Irum Khan, MBBS6

1University of Chicago Ingalls Memorial Hospital, Harvey, IL
2Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, IL
3Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL
4Department of Medicine, University of Chicago, Chicago, IL
5Northwestern University, Chicago, IL
6Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
7Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL
8Rush University Medical Center, Chicago, IL
9Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
10Department of Cancer Biology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL
11John H Stroger Jr. Hospital of Cook County, Chicago, IL
12John H Stroger Jr Hospital of Cook County, Chicago, IL
13Rush University Cancer Center, Rush University Medical Center, Chicago, IL
14University of Chicago, Chicago, IL

Hussein A Abbas, MD, PhD1, Edward Ayoub, PhD2*, Hanxiao Sun3*, Rashmi Kanagal-Shamanna, MD4, Nicholas Short, MD5, Ghayas C. Issa, MD5,6, Musa Yilmaz, MD7, Sherry A. Pierce, BSN, BA1*, Daniel Rivera, MD1*, Brent Cham8*, Shane Wing8*, Ziyi Li, PhD9*, Danielle Hammond, MD1, Elias Jabbour, MD1, Gautam Borthakur, MD1, Guillermo Garcia-Manero, MD10, Michael Andreeff, MD, PhD1, Naval Daver, MD11, Tapan M. Kadia, MD7, Marina Konopleva, MD, PhD12, Courtney D. DiNardo, MD, MSCE1 and Farhad Ravandi, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston
4Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
7Department of Leukemia, MD Anderson Cancer Center, Houston, TX
8The University of Texas Health Science Center, Houston
9Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
11MD Anderson Cancer Center, Houston, TX
12MD Anderson Cancer Center, Houston, TX

Maximilian F. Stahl, MD1, Gerard Giblin2*, Yiwen Liu3*, Daniel J DeAngelo, MD, PhD4, Richard M. Stone, MD4, Eric S. Winer, MD5, Martha Wadleigh, MD5, Coleman Lindsley, MD, PhD5, Shai Shimony, MD5*, Kevin Copson, MA5*, Anne Charles6*, Anju Nohria, MD7* and Marlise R. Luskin, MD5

1Department of Medical Oncology, Dana-Farber Institute, Boston, MA
2Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6Dana-Farber Cancer Institute, Boston, MA
7Brigham Women's Health, Boston, MA

Kensuke Matsuda, MD, PhD1, Taisuke Jo2*, Hideo Yasunaga, MD, PhD3* and Koichi Sugimoto, MD, Ph.D,1*

1Department of Hematology and Oncology, JR Tokyo General Hospital, Tokyo, Japan
2Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
3Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan

Michael Heuser, MD1, Nouraldin Damrah, MD2*, Razif Gabdoulline, PhD2*, Courteney K. Lai, PhD3*, Eric Sträng, PhD4*, Mustafa Salim, MD5*, Gudrun Göhring, MD6*, Yvonne L. Behrens, Dr. rer. nat.5*, Ekaterina Jahn, MD7*, Martin Wichmann2*, Jens F. Schrezenmeier4*, Yasmine Alwie2*, Joerg Westermann8, Frederick Damm, MD4*, Brigitte Schlegelberger, MD9, Frank G. Rücker, MD10*, Hartmut Döhner, MD7, Arnold Ganser, MD2*, Felicitas R. Thol, MD1, Olga Blau, MD11, Konstanze Döhner, MD12, Lars Bullinger, MD4 and Anna Dolnik, PhD4*

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
3Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625, Germany
4Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany
5Department of Human Genetics, Hannover Medical School, Hanover, Germany
6Department of Human Genetics, Hannover Medical School, Hannover, Germany
7Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
8Department of Hematology, Oncology and Tumor Immunology, Campus Virchow-Clinic, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
9Department of Human Genetics, Hannover Medical School (MHH), Hannover, Germany
10Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
11Department of Hematology, Oncology and Tumor Immunology, Charite University Medicine Berlin, Berlin, Germany
12Division of Hematology and Oncology, University Hospital Ulm, Ulm, Germany

Lukas Ronner, MD MSCR1, Heather M. Giannini, MD MS2*, Todd A. Miano, PhD PharmD2*, Caroline A. G. Ittner, PhD2*, Alexandra P. Turner, BS2*, Thomas G. Dunn, BA2*, Roseline S. Agyekum, BS2*, Anushka Dasgupta2*, Kirsten West2*, Tiffanie K. Jones, MD MPH MSCE2*, Michael G. S. Shashaty, MD MSCE2*, John P. Reilly, MD MSCE2* and Nuala J. Meyer, MD MS2*

1Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
2Division of Pulmonary and Critical Care Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Hisashi Ishida, MD, PhD1, Shin-ichi Tsujimoto, MD, PhD2*, Daisuke Hasegawa, MD, PhD3*, Hirotoshi Sakaguchi, MD, PhD4, Shohei Yamamoto, MD, PhD5*, Masakatsu Yanagimachi, MD, PhD6*, Katsuyoshi Koh, MD7*, Akihiro Watanabe, MD, PhD8*, Asahito Hama, MD, PhD9*, Yuko Cho, MD, PhD10*, Kenichiro Watanabe, MD, PhD11*, Maiko Noguchi, MD12*, Masanobu Takeuchi, MD2*, Junko Takita, MD, PhD13*, Kana Washio, M.D., Ph.D.1*, Yoshiko Hashii, MD, PhD14, Ken Tabuchi, MD15*, Moeko Hino, MD16*, Yoshiko Atsuta17,18* and Yasuhiro Okamoto, MD, PhD19

1Department of Pediatrics, Okayama University Hospital, Okayama, Japan
2Department of Pediatrics, Yokohama City University, Yokohama, Japan
3Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan
4Department of Transplantation and Cellular Therapy, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
5Department of Pediatrics, Tokai University, Kanagawa, JPN
6Division of Hematology/Oncology, Kanagawa Children's Medical Center, Kanagawa, Japan
7Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
8Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan
9Department of Hematology and Oncology, Children’s Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital, Nagoya, Nagoya, Japan
10Department of Pediatrics, Hokkaido University Hospital, Sapporo, Japan
11Department of Hematology and Oncology, Shizuoka Children’s Hospital, Shizuoka, Japan
12Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan
13Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
14Department of Pediatrics, Osaka International Cancer Institute, Osaka, Japan
15Tokyo Cancer Registry, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan
16Department of Pediatrics, Chiba University Hospital, Chiba, Japan
17Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
18Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
19Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

Edwin Uriel Suárez1*, Juan Manuel Alonso1*, Blanca Boluda2*, Esperanza Lavilla3*, Mar Tormo4,5, Carmen Botella6*, Susana Vives, PhD7*, Carlos Rodriguez8*, Josefina Serrano9,10*, María José Sayas11*, Pilar Martínez Sánchez12*, Fernando Ramos13*, Teresa Bernal del Castillo14*, Lorenzo Algarra15*, Juan Miguel Bergua Burgués16*, José Pérez-Simón17,18, Pilar Herrera19*, Manuel Barrios-García20*, Víctor Noriega-Concepción21*, Jóse Ángel Raposo-Puglia22*, Rosa Ayala23,24*, Eva Barragán2*, David Martinez-Cuadron2* and Pau Montesinos, MD, PhD2*

1Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain
2Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
3Hospital Universitario Lucus Augusti, Lugo, Spain
4Hospital Clínico Universitario de Valencia, Valencia, Spain
5INCLIVA, Valencia, Spain
6Hospital General Universitario de Alicante, Alicante, Spain
7ICO-Hospital Germans Trias i Pujol, Badalona, Spain
8Hospital Universitario Dr Negrín, Las Palmas, Spain
9Hospital Universitario Reina Sofía, Córdoba, Spain
10IMIBIC, Cordoba, Spain
11Hospital Universitario Dr. Peset, Valencia, Spain
12Hospital Universitario 12 de Octubre, Madrid, Spain
13Hospital Universitario de León, León, Spain
14Hospital Universitario Central de Asturias, Oviedo, Spain
15Hospital Universitario General de Albacete, Albacete, Spain
16Hospital San Pedro de Alcántara, Cáceres, Spain
17Hospital Universitario Virgen del Rocío, Sevilla, Spain
18Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Sevilla, Spain
19Hospital Universitario Puerta de Hierro, Majadahonda, Spain
20Hospital Regional Universitario de Málaga, Málaga, Spain
21Hospital Universitario de A Coruña, A Coruña, ESP
22Hospital Universitario Puerta del Mar de Cádiz, Cádiz, Spain
23Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC, Madrid, Spain
24Spanish National Cancer Research Center (CNIO), Madrid, Spain

Gabrielle Paras, MD1*, Megan Othus, PhD2,3, Carole M. Shaw, BA4*, Katie Russell, ARNP5*, Anna B. Halpern, MD6,7, Jacob S. Appelbaum, MD, PhD6,8, Paul C. Hendrie, MD, PhD1,8, Roland B. Walter, MD, PhD, MS1,4,9 and Mary-Elizabeth M. Percival, MD1,5

1Department of Medicine, University of Washington, Seattle, WA
2Department of Biostatistics, University of Washington School of Public Health, Seattle, WA
3Division of Public Health, Fred Hutchinson Cancer Research Center, Seattle, WA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Fred Hutchinson Cancer Center, Seattle, WA
6Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
7Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
8Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
9Department of Epidemiology, University of Washington, Seattle, WA

Katharina Waack1,2*, Daniel Weber3*, Stephanie Sendker, MD4* and Dirk Reinhardt, MD5

1Pediatric Research Network, Essen, Germany
2Pediatric Hematology/Oncology, University Hospital Essen, Essen, DEU
3Department of Pediatrics III, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany
4Department of Pediatrics III, University Hospital Essen, Essen, Germany
5Department of Pediatrics III, University Children’s Hospital Essen, University Duisburg-Essen, Essen, Germany

Katharina Waack1,2*, Franziska Budeus3*, Evangelia Antoniou, MD4 and Dirk Reinhardt, MD5

1Pediatric Research Network, Essen, Germany
2Pediatric Hematology/Oncology, University Hospital Essen, Essen, DEU
3Department of Pediatrics III, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany
4Department of Pediatrics III, University Hospital Essen, Essen, Germany
5Department of Pediatrics III, University Children’s Hospital Essen, University Duisburg-Essen, Essen, Germany

Jatinder K. Lamba, PhD1, Xueyuan Cao, PhD2*, Huiyun Wu, PhD3*, Hiroto Inaba, MD, PhD4, Raul C. Ribeiro, MD5, Junmin Peng, Ph.D.6*, Tanja A. Gruber, MD7, Jeffrey E. Rubnitz, MD4 and Stanley B. Pounds, PhD8*

1UF Health Cancer Center, Gainesville, FL
2Department of Health Promotion and Disease Prevention, University of Tennessee Health Science Center, Memphis, TN
3Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
4Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
5St. Jude Children's Research Hospital, Memphis, TN
6Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN
7Pediatrics, Stanford University School of Medicine, Palo Alto, CA
8Biostatistics, St. Jude Children's Research Hospital, Memphis, TN

Rahul Shah, MD1*, J. Matthew Luther, MD2*, Michael Byrne, DO3, Dae Kwang Jung1*, Salyka M. Sengsayadeth, MD4*, Bhagirathbhai Dholaria, MBBS4, Adetola A. Kassim, MBBS, MS5, Bipin N. Savani, MD4, Wichai Chinratanalab, MD4, Reena Jayani, MD4 and Brian G. Engelhardt, MD4

1Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
2Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN
3Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN
4Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
5Department of Medicine, Divison of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN

Xiaoqin Feng1*, Chunfu Li, MD2, Jian Li, MD3*, Mincui Zheng4*, Sixi Liu, MD, PhD5*, Lihua Yang, MD PhD6*, Hua Jiang, MD7*, Honggui Xu8*, Hong Wen9* and Xiangling He10*

1Department of Pediatrics, Nanfang Hospital, Guangzhou, China
2Nanfang-Chunfu Children's Institute of Hematology & Oncology, Taixin Hospital, Dongguan, China
3Department of Hematology, Fujian Medical University Union Hospital,Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China
4Hematology and Oncology, Hunan Children's Hospital, Changsha, China
5Department of Hematology -Oncology, Shenzhen Children's Hospital, Shenzhen, China
6Zhujiang Hospital, Southern Medical University, Guangzhou, China
7hematology and oncology, Guangzhou Women and Children's Medical Center, Guangzhou, CHN
8Sun Yat-sen Memorial Hospital, Guangzhou, China
9Pediatrics, The First Affiliated Hospital of Xiamen University, Xiamen, China
10Hunan Provincial People's Hospital, Changsha, CHN

Anna R. Blankstein1*, Neelan Sriranjan, MD1,2, Nora Choi3*, Kristjan Paulson1,2, David Sanford, MD4, Lee Mozessohn5, Donald S. Houston1,2, Emily Rimmer1,2, Sylvain Lother6,7*, Asher Mendelson7*, Allan Garland7*, Rena Buckstein5, Annette E. Hay8, Ryan Zarychanski, MD1,2 and Brett L. Houston1,2

1Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
2Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
3University of Manitoba, Winnipeg, MB, Canada
4The Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
5Division of Hematology/Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
6Section of Infectious Diseases, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
7Section of Critical Care, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
8Department of Medicine, Queen's University, Kingston, ON, Canada

Mihee Kim, MD1*, Taehyung Simon Kim2*, Seo-Yeon Ahn, MD1*, Sung-Hoon Jung, MD3*, Ga-Young Song, MD4*, Deok-Hwan Yang, MD, PhD5*, Je-Jung Lee, MD, PhD6, Seunghyun Choi, PhD7*, MiYeon Kim7*, Jae-Sook Ahn, MD, PhD3*, Hyeoung-Joon Kim, MD, PhD8 and Dennis Kim, MD, PhD9

1Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea, Republic of (South)
2Computer science, University of Toronto, Toronto, ON, Canada
3Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
4Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanam-Do, KOR
5Chonnam National University Hwasun Hospital, Gwangju, Korea, Republic of (South)
6Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of (South)
7Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun-gun, Korea, Republic of (South)
8Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea, Republic of (South)
9Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Suvir Singh, DM1*, Sharon Lionel, MBBS, MD, DM2*, Hasmukh Jain, MD, DM3*, Lingaraj Nayak, MD, DM3*, Sushil Selvarajan, MD, DM2*, Prasanna Samuel, MSc, PhD4*, Rayaz Ahmed, MD, DM5, Narendra Agrawal, MD, DM5*, Pavitra DS, MD6*, Poojitha Byreddy, MD6*, Joseph M John, MD, DM6*, Kundan Mishra, MD, DM, MNAMS7*, Suman Kumar, MD, DM7*, Mobin Paul, MBBS, MD, DM8*, Latha Abraham, MD9*, Smita Kayal, MD, DM10*, Prasanth Ganesan, MD, DM10*, Chepsy C Philip, MD, MBBS, DM11, Damodar Das, MD, DNB12*, Sreeraj Vasudevan, DM13*, Prashant Mehta, MD, DM14*, Jayachandran PK, MD, MRCP, DM15*, Vineetha Raghavan, MD16*, Stalin Chowdary Bala, MBBS, MD, DM, DNB17*, Bharath Ram S, MBBS, DNB18, Swaratika Majumdar, MD, DM19*, Akhil Rajendra, MD3*, Om Prakash, MSc4*, Barath U20*, Bhausaheb Bagal, MD, DM3*, Aby Abraham, MD, DM2*, Rajan Kapoor, MD, DM7*, Dinesh Bhurani, MD, FRCPA5*, Manju Sengar, MD, DM 3 and Vikram Mathews, MD, DM2

1Department of Clinical Haematology, Dayanand Medical College and Hospital, Ludhiana, India
2Department of Haematology, Christian Medical College, Vellore, India
3Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
4Department of Biostatistics, Christian Medical College, Vellore, India
5Department of Haemato-Oncology & BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
6Department of Clinical Haematology, Christian Medical College, Ludhiana, India
7Department of Clinical Haematology, Army Hospital (Research & Referral), New Delhi, India
8Clinical Haematology and Haemato-oncology, Rajagiri Hospital, Aluva, India
9Department of Pathology, Rajagiri Hospital, Aluva, IND
10Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry, India
11Regional Advanced Centre for (Stem Cell) Transplant, Hemato-Lymphoid Oncology & Marrow Diseases, Believers Church Medical College Hospital, Thiruvalla, India
12Department of Clinical Hematology, Gauhati Medical College & Hospital, Guwahati, India
13Department of Medical Oncology and Haematology, Amala Institute of Medical Sciences, Thrissur, India
14Department of Medical Oncology and BMT, Asian Institute of Medical Sciences, Faridabad, India
15Department of Medical Oncology, Cancer Institute (WIA), Chennai, Tamilnadu, India
16Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, India
17Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India
18Department of Hematology, Mazumdar Shaw Medical Center, Narayana Health City, Bangalore, India
19Department of Medical Oncology, Ramaiah Medical College, Bengaluru, India
20Department of Biostatistics, Christian Medical College, Vellore, Vellore, India

Emma E Williams, MD1*, Danielle McQuinn, MD1*, Lauren G. Banaszak, MD2, Cameron Ninos1*, Ryan J. Mattison, MD3, Zhubin Gahvari, MD4, Aric C. Hall, MD5*, Michael J Fallon, PharmD6* and Kalyan VG Nadiminti, MD1

1University of Wisconsin Hospital, Madison, WI
2Division of Hematology/Oncology/Palliative Care, University of Wisconsin School of Medicine and Public Health, Madison, WI
3University of Wisconsin Hospitals, Madison, WI
4University of Wisconsin, Madison, WI
5Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
6University of Wisconsin Hospital and Clinics, Madison, WI

Adam J. Lamble, MD1, Yueh-Yun Chi2*, Bill H. Chang, MD, PhD3, Anupam Verma, MD4, Kelly E Faulk, MD5, Alexandra McLean Stevens, MD, PhD6, Lauren Pommert, MD7, Sarah Tucker, PharmD1*, Benjamin Brookhart2*, Nirali N. Shah, MD8, Christopher L. Brooks, PhD9, Tariq I. Mughal, MD, FRCP10*, Alan S. Wayne, MD2, Soheil Meshinchi, M.D., Ph.D.11 and Todd M. Cooper, DO1

1Seattle Children's Hospital, Seattle, WA
2Children's Hospital Los Angeles, Los Angeles, CA
3OHSU, Portland, OR
4NIH, Bethesda
5Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO
6Department of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
7University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
8Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
9Stemline Therapeutics Inc, New York, NY
10Stemline Therapeutics, New York, NY
11Fred Hutchinson Cancer Center, Seattle, WA

Marta Isabel Pereira1, Gilberto Marques, MD2*, Sandra Marini, MD3*, Emília Cortesão, MD, PhD3*, Catarina Chaves, MD2*, Fernando Rodrigues, MD2* and Catarina Geraldes, MD, PhD3*

1Clinical Hematology Department, Coimbra University, Coimbra, Portugal
2Clinical Pathology Department, Coimbra University Hospitals, Coimbra, Portugal
3Clinical Hematology Department, Coimbra University Hospitals, Coimbra, Portugal

Jinjin Wang*, Hui Zhou*, Mengyao Wang*, Ailin Zhao* and Ting Niu

Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China, Chengdu, Sichuan, China

Michal Jakub Kubiak, MD1, Anand P. Jillella, MD2, Danielle Bradshaw, MD2*, Natasha M. Savage, MD3, Locke J. Bryan, MD2, Ravindra Kolhe, MD, PhD4* and Vamsi K. Kota, MD2

1Augusta University, Augusta, GA
2Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
3Department of Pathology, Augusta University Medical Center, Augusta, GA
4Department of Pathology, Augusta University, Augusta, GA

Kevin Hai-Ning Lu1, Lina Hoffmeister2*, Eser Orhan3*, Markus Schneider, PhD1,4*, Katharina Waack5*, Helmut Hanenberg, MD6*, Nils von Neuhoff, PhD7* and Dirk Reinhardt, MD8

1Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
2Department of Pediatrics III, University Hospital Essen, Essen, Germany
3Centre for Research Acceleration in Pediatrics GmbH, Essen, Germany
4Department of Pediatrics III, University Children’s Hospital Essen, University Duisburg-Essen, Essen, Germany
5Pediatric Hematology/Oncology, University Hospital Essen, Essen, DEU
6Department of Pediatrics III, University Children's Hospital Essen, University of Duisburg-Essen, Essen, Germany
7Clinic of pediatrics III, University Hospital of Essen, Essen, Germany
8Department of Pediatric Oncology, University Hospital Essen, Essen, Germany

Nikhil Patel, MD1*, Gustavo Rivero, MD2,3,4, Martha P. Mims, MD, PhD2,3,4, Purnima Sravanti Teegavarapu, MD2,3,4, Gianfranco Bittar, MD5* and Diana De Oliviera6*

1Department of Medicine, Baylor College of Medicine, Houston, TX
2Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX
3Department of Hematology/Oncology, Baylor St Luke's Medical Center, Houston, TX
4Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX
5Baylor St Luke's Medical Center, Houston, TX
6Baylor St. Luke's Medical Center, Houston

*signifies non-member of ASH